Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|13|1215-1224

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.13, 2014-12, pp. : 1215-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 870-881

Bentham Science Publishers

Access to resources Recommend Favorite

Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)

By  

Current Cancer Drug Targets, Vol. 15, Iss. 3, 2015-05 ,pp. : 243-255

Bentham Science Publishers

Access to resources Recommend Favorite

Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 408-419

Bentham Science Publishers

Access to resources Recommend Favorite

Genomic biomarkers, androgen pathway and prostate cancer

By D’’Amico Franca   Biancolella Michela   Margiotti Katia   Reichardt Juergen KV   Novelli Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 645-661

Future Medicine

Access to resources Recommend Favorite

Castration Resistant Prostate Cancer: From Emerging Molecular Pathways to Targeted Therapeutic Approaches

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 11-27

Bentham Science Publishers

Access to resources Recommend Favorite